Clinical Trial Update: Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating withdrawal of α-blocker or 5-ARI to maintain combination therapy for lower urinary tract symptoms in men with benign prostatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Prostatic Hyperplasia, Prostate Hyperplasia | Phase 3 | Status: UNKNOWN